Canada markets open in 3 hours 40 minutes

Aprea Therapeutics, Inc. (APRE)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
5.10-0.16 (-2.95%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
7,627
7,627
16,402
23,896
37,879
Selling General and Administrative
8,428
8,428
20,970
13,550
14,932
Total Operating Expenses
15,472
15,472
37,372
37,446
52,811
Operating Income or Loss
-15,472
-15,472
-37,372
-37,446
-52,811
Total Other Income/Expenses Net
-38.926
-38.926
-75,739
317.402
-890.252
Income Before Tax
-14,287
-14,287
-112,662
-37,127
-53,479
Income from Continuing Operations
-14,287
-14,287
-112,662
-37,127
-53,479
Net Income
-14,287
-14,287
-112,662
-37,127
-53,479
Net Income available to common shareholders
-14,287
-14,287
-112,662
-37,127
-53,479
Basic EPS
12.31
-
-67.99
-34.88
-50.61
Diluted EPS
12.31
-
-67.99
-34.88
-50.61
Basic Average Shares
3,348
-
1,657
1,064
1,057
Diluted Average Shares
3,348
-
1,657
1,064
1,057